Results of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Westeel, V. [1 ]
Barlesi, F. [2 ]
Foucher, P. [3 ]
Lafitte, J-J. [4 ]
Domas, J. [5 ]
Girard, P. [6 ]
Tredaniel, J. [7 ]
Wislez, M. [8 ]
Dumont, P. [9 ]
Quoix, E. [10 ]
Raffy, O. [11 ]
Braun, D. [12 ]
Derollez, M. [13 ]
Goupil, F. [14 ]
Hermann, J. [15 ]
Devin, E. [16 ]
Pichon, E. [17 ]
Gury, J-P. [18 ]
Morin, F. [19 ]
Souquet, P-J. [20 ]
机构：
[1] Hop Jean Minjoz, CHRU Besancon, Pneumol, Besancon, France
[2] Aix Marseille Univ, AP HM, Multidisciplinary Oncol & Therapeut Innovat, Marseille, France
[3] CHU Le Bocage Dijon, Pneumol, Dijon, France
[4] CHRU Lille, Hop Calmette, Pneumol, Lille, France
[5] Ctr Catalan Oncol Clin St Pierre, Pneumol, Perpignan, France
[6] Inst Mutualiste Montsouris, Pneumol, Paris, France
[7] Hop St Joseph, Pneumol, Paris, France
[8] Tenon Univ Hosp, AP HP, Pneumol, CancerEst, Paris, France
[9] Ctr Hosp, Pneumol, Chauny, France
[10] CHU Strasbourg, Serv Pneumol, Pole Pathol Thorac, NHC, Strasbourg, France
[11] Ctr Hosp, Pneumol, Chartres, France
[12] Cabinet, Pneumol, Briey, France
[13] Clin Val de Sambre, Pneumol, Maubeuge, France
[14] Ctr Hosp, Pneumol, Le Mans, France
[15] HPMetz Hop Robert Schuman, Pneumol, Metz, France
[16] CHI EureSeine Evreux, Pneumol, Evreux, France
[17] CHRU Bretonneau, Pneumol, Tours, France
[18] Ctr Hosp, Pneumol, Vesoul, France
[19] French Cooperat Thorac Intergrp, Clin Res Unit, Paris, France
[20] Ctr Hosp Lyon Sud, Pneumol, Pierre Benite, France
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1273O
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Significance of the serum carcinoembryonic antigen level during the follow-up of patients with completely resected non-small-cell lung cancer
    Ozeki, Naoki
    Fukui, Takayuki
    Taniguchi, Tetsuo
    Usami, Noriyasu
    Kawaguchi, Koji
    Ito, Simon
    Sakao, Yukinori
    Mitsudomi, Tetsuya
    Hirakawa, Akihiro
    Yokoi, Kohei
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2014, 45 (04) : 687 - 692
  • [42] Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial
    Anish B. Parikh
    Peter Kozuch
    Nicholas Rohs
    Daniel J. Becker
    Benjamin P. Levy
    Investigational New Drugs, 2017, 35 : 813 - 819
  • [43] Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial
    Parikh, Anish B.
    Kozuch, Peter
    Rohs, Nicholas
    Becker, Daniel J.
    Levy, Benjamin P.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 813 - 819
  • [44] IFCT0002 phase III study comparing a preoperative (PRE) and a perioperative (PERI) chemotherapy with two different CT regimens in resectable non-small cell lung cancer (NSCLC): Early results
    Milleron, B.
    Quoix, E.
    Westeel, V.
    Puyraveau, M.
    Braun, D.
    Breton, J. L.
    Game, L. Bigay
    Pujol, J. L.
    Morin, F.
    Depierre, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] RASSF1/hippo pathway molecular dissection in patients with resectable non-small cell lung cancer (NSCLC) treated by perioperative chemotherapy (CT) in the phase III trial IFCT-0002
    Zalcman, Gerard
    Levallet, Guenaelle
    Do, Hongdo
    De Fraipont, Florence
    Mounawar, Mounia
    Beau-Faller, Michele
    Bergot, Emmanuel
    Morin, Franck
    Creveuil, Christian
    Dobrovic, Alexander
    Hainaut, Pierre
    Milleron, Bernard
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S362 - S362
  • [46] Advanced age is associated with lack of administration of adjuvant chemotherapy for completely resected stage IB-III non-small cell lung cancer (NSCLC)
    Riely, Gregory J.
    Seshan, V. E.
    Azzoli, C. G.
    Kris, Mark G.
    Rusch, Valerie W.
    Park, Bernard K.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S454 - S454
  • [47] IS PET/CT A BETTER TOOL THAN CT IN RESPONSE EVALUATION AND FOLLOW-UP OF STAGE III NON-SMALL CELL LUNG CANCER AFTER CHEMORADIOTHERAPY?
    Yumuk, Perran F.
    Besiroglu, Mehmet
    Dane, Faysal
    Kanitez, Metin
    Aktas, Bilge
    Caglar, Hale
    Yildizeli, Bedrettin
    Dede, Fuat
    Atasoy, Besrte
    Turhal, Nazim S.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S559 - S559
  • [48] A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Han, Baohui
    Li, Kai
    Zhao, Yizhuo
    Wang, Qiming
    Zhang, Li
    Shi, Jianhua
    Wang, Zhehai
    He, Jianxing
    Shi, Yuankai
    Cheng, Yin
    Chen, Weiqiang
    Wang, Xiuwen
    Luo, Yi
    Nan, Kejun
    Jin, Faguang
    Dong, Jian
    Li, Baolan
    Zhou, Jianying
    Chen, Yinlan
    Wang, Donglin
    Zhou, Xin
    Yu, Yan
    Chen, Liming
    Liu, Anwen
    Huang, Jianjin
    Huang, Cheng
    Cao, Bangwei
    Chen, Jun
    Ma, Rui
    Yu, Zhuang
    Ding, Cuimin
    Wang, Hongbing
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S886 - S887
  • [49] A phase III randomised trial comparing sequential to standard chemotherapy in advanced non-small cell lung cancer (NSCLC).
    Sculier, J.
    Lafitte, J.
    Lecomte, J.
    Alexopoulos, C.
    Van Cutsem, O.
    Giner, V.
    Efremidis, A.
    Scherpereel, A.
    Paesmans, M.
    Berghmans, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 367S - 367S
  • [50] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC): a randomised phase III trial
    McDonald, F.
    Mak, K. M.
    Teague, J.
    Landau, D.
    Hanna, G.
    Farrelly, L.
    Counsell, N.
    LUNG CANCER, 2020, 139 : S91 - S91
12345